Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
Linear Formula:
Li
CAS Number:
Molecular Weight:
6.94
NACRES:
NA.23
PubChem Substance ID:
UNSPSC Code:
12141803
MDL number:
Product Name
Lithium, foil, not light tested, 38x200mm, thickness 0.20mm, as rolled, 99.9%
InChI
1S/Li
SMILES string
[Li]
InChI key
WHXSMMKQMYFTQS-UHFFFAOYSA-N
assay
99.9%
form
foil
manufacturer/tradename
Goodfellow 621-585-96
resistivity
9.446 μΩ-cm, 20°C
size × thickness
38x200 mm × 0.20 mm
bp
1342 °C (lit.)
mp
180 °C (lit.)
density
0.534 g/mL at 25 °C (lit.)
Looking for similar products? Visit Product Comparison Guide
Related Categories
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Storage Class
4.3 - Hazardous materials which set free flammable gases upon contact with water
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Xianglong Li et al.
Nanoscale, 5(19), 8864-8873 (2013-08-15)
The implementation of silicon (Si) in practical lithium ion battery electrodes has been hindered due to its large volume change and consequent structural and interfacial instabilities. Coating nanostructured Si with a second phase (e.g., carbon (C)) represents a very promising
Susan W Lehmann et al.
Journal of affective disorders, 146(2), 151-157 (2012-09-19)
Lithium has been reported to induce hypercalcemia and hyperparathyroidism, yet few studies have examined the impact on older patients. We therefore undertook this review and report our findings. We undertook a systematic review of articles on lithium-associated hypercalcemia and/or hyperparathyroidism
Rebecca F McKnight et al.
Lancet (London, England), 379(9817), 721-728 (2012-01-24)
Lithium is a widely used and effective treatment for mood disorders. There has been concern about its safety but no adequate synthesis of the evidence for adverse effects. We aimed to undertake a clinically informative, systematic toxicity profile of lithium.
Mustafa Khasraw et al.
BMC medicine, 10, 131-131 (2012-11-06)
Neurocognitive impairment is being increasingly recognized as an important issue in patients with cancer who develop cognitive difficulties either as part of direct or indirect involvement of the nervous system or as a consequence of either chemotherapy-related or radiotherapy-related complications.
Rasmus W Licht
CNS neuroscience & therapeutics, 18(3), 219-226 (2011-11-11)
Still after more than 50 years, lithium is a major treatment of bipolar disorder, even though it has not been promoted by the pharmaceutical industry over the last decades. In recent years the evidence base on lithium for bipolar disorder
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service